Impact of renal failure on survival of African patients with cirrhosis.
To assess the effect of renal failure on the survival of black African patients with cirrhosis, we studied 132 (82 males, 50 females) cirrhotic black African patients with mean age of 47.5+/-14.4 years and mean follow-up period of 373+/-194 days. The edema and ascitis were the main reasons for admission to hospital. Renal failure was present in 30 (22.7%) patients, and it was positively correlated to the severity of the stage of the liver disease, and associated with severe hyponatremia. Survival at 1 year was 60.1% and 37.6% in the absence or presence of renal failure, respectively (p<0.001)). The stage of the liver disease was significantly inversely correlated with survival, which was further diminished in the presence of renal failure:23.7% versus 12.5% for Child-Pugh-Turcote (CPT) A-B in the absence or presence of renal failure, respectively (p=0.67), 30.2% versus 81.8% for CPT C in the absence or the presence of renal failure respectively (p<0.001). Hyponatremia has also appeared detrimental to survival, since mortality was 38.4% versus 81.8% in the absence or the presence of hyponatremia respectively (p<0.001). By multivariate analysis, renal failure, CPT stage C, and hyponatremia independently significantly correlated to mortality in patients with cirrhosis. We conclude that renal failure is frequently associated with decompensated cirrhosis. The presence of renal failure in this setting often results in high mortality. Renal failure that occurs in the setting of a severe liver disease and hyponatremia may be part of hepatorenal syndrome.
Attia
K A
KA
Service of Hepatology and Gastroenterology, Yopougon Teaching Hospital, Abidjan, Ivory Coast. attia_alain@yahoo.fr
N'dri Yoman
A T
AT
Mahassadi
A K
AK
Ackoundou-N'guessan
K C
KC
Kissi
H Y
HY
Bathaix
Y F
YF
D000328:Adult; D053099:Azotemia / Q000150:complications; D044383:Black People; D015331:Cohort Studies; D007560:Cote d'Ivoire / Q000453:epidemiology; D003404:Creatinine / Q000097:blood; D005260:Female; D005355:Fibrosis / Q000150:complications* / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D011336:Probability; D051437:Renal Insufficiency / Q000209:etiology / Q000401:mortality*; D012964:Sodium / Q000097:blood; D016019:Survival Analysis
D012964:Sodium; D003404:Creatinine